Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit
A jury determined that Invitae and ArcherDx have infringed three patents and awarded Natera damages for lost profits and past royalties.
Pillar Biosciences Licenses KeyGene NGS IP
The intellectual property relates to the use of a combination of two or more nucleotide sequence identifiers in the preparation of a sample DNA for high-throughput sequencing.
Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.
Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute
An appeals court has affirmed an earlier decision to uphold two patents related to microfluidic device construction.
Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit
A federal jury ruled that various Qiagen sample prep products infringe a pair of US patents underlying ArcherDx's anchored multiplex PCR technology.